DCIS 411

10/12/2026

We’ve heard a lot about dense breasts this month, but WHY do some women have dense breast tissue, and what imaging options are available? 🧡

Genetics, hormones, age, and other factors influence breast density. Dense tissue makes cancers harder to detect on a mammogram. Supplemental imaging, such as whole-breast ultrasounds and QT imaging help provide additional information.

Swipe to discover questions to ask about your breast density and imaging options.

Learn more at DCIS411.com.

10/11/2026

Great Wisdom from Dr. Thomas Lodi! 💥 A few highlights:

* Don’t use their language (the cancer industry)!
* Fear requires an exorcism
* Hum

Transforming your health is more fun with friends!Join Chef AJ’s E...

10/10/2026

📣 Important DCIS Policy Update!

Medicare contractor Noridian has dropped its proposed restriction on biomarker testing used to assess DCIS risk, effective October 8, 2026.

As a result, the October 13 meeting to discuss the proposed policy has been cancelled.

This is an important development for DCIS patients and advocates as clinical evidence continues to evolve. Patients deserve access to evidence-based information to make informed treatment decisions.

Read more at https://med.noridianmedicare.com/web/jfa/article-detail/-/view/10529/moldx-biomarker-testing-for-risk-stratification-in-dcis-retirement-effective-october-8-2026

10/10/2026

🧡 Representing DCIS. Raising Awareness. Empowering Women.

Yelena represented DCIS 411 at a breast cancer awareness event, educating women about Ductal Carcinoma In Situ (DCIS), the importance of informed decision-making, and emerging breast imaging technologies.

We’re excited to be an official 501(c)(3) nonprofit organization! 🎉

Your support helps us expand DCIS education, advocacy, and resources for women navigating DCIS diagnosis.

🙏 Donate today: https://givebutter.com/DCIS411

🧡 Give women facts, not fear.

10/09/2026

"Stage 0" shouldn't mean zero answers. 💬

Every year, 60,000+ women in the U.S. are diagnosed with DCIS (Ductal Carcinoma In Situ), often called Stage 0 breast cancer.

Is it cancer? Pre-cancer? Overdiagnosis?

DCIS is non-invasive, yet it's often treated like invasive cancer, with surgery, radiation, and hormone therapy. Many women are never told how much the experts still debate.

This October, we're asking for something simple: women deserve better information.

✔️ Evidence-based education
✔️ Breast imaging awareness
✔️ Breast cancer prevention
✔️ Patient advocacy & support

Get the facts. Know your options. 👉 dcis411.com

10/08/2026

🚨 Important conversations about DCIS are happening at SSO 2026.

As the Society of Surgical Oncology brings together breast cancer experts, de-escalation and active monitoring are increasingly part of the conversation.

DCIS patients are asking: “Do I really need surgery?”

Trials including COMET, LORIS, LORD and LORETTA are studying whether selected patients can safely choose active monitoring instead of immediate surgery.

Patients are asking for this option. Research is finally catching up.

DCIS 411 believes women deserve facts, options, and informed consent, not fear.

At the 2026 Society of Surgical Oncology conference, experts detailed recent advances in their respective fields, including a presentation on breast cancer.

10/07/2026

🎉 Another important commercial step for QT Imaging.

Hospitals and health systems that are Premier members now have an easier, established pathway to purchase the QT Breast Acoustic CT scanner. Premier’s network includes nearly 4,400 hospitals and health systems across the U.S.

This expands the commercial pathway for QT and makes it easier for healthcare organizations to move from interest in the technology to actually purchasing the system. It removes some of the procurement hurdles because QT is now included in a national purchasing agreement, rather than each hospital having to negotiate a purchasing arrangement independently.

A meaningful step toward broader access to QT Imaging technology.

Agreement provides access to 4,400 U.S. hospitals and health systems and provides Premier members pre-negotiated pricing and terms NOVATO,…...

10/06/2026

10/06/2026

Abus 3d ultrasound is coming to NY on October 17th Breast Screening Ultrasound is $349 📍 10 W 18th St, New York, NY 👇
https://app.besoundbreast.com/book-appointment?start

10/05/2026

Comment PINTO and I’ll send you a link to the full interview.

It’s officially Breast Cancer Awareness Month again, and I’m kicking it off with a topic you probably won’t hear much about in mainstream media: DCIS.

More than 60,000 women in the U.S. will be diagnosed with DCIS, also known as “stage 0 breast cancer,” this year.

“Stage 0 breast cancer” is a controversial term because DCIS is not actually breast cancer.

Ductal carcinoma in situ is the presence of abnormal “pre-cancerous” cells inside milk ducts, which have not spread to surrounding breast tissue.

Up to 80% of DCIS cases may never progress to invasive breast cancer; still, many women are rushed into aggressive, disfiguring treatment out of fear.

My guest on this week’s podcast, Donna Pinto, was diagnosed with DCIS in 2010 and was given two options: a partial mastectomy plus radiation or a full mastectomy.

Donna said no to treatment, healed her DCIS naturally, and has spent the last 16 years educating women about DCIS overdiagnosis and overtreatment.

In our interview, we talk about what women should know about DCIS, mammography, conflicting pathology reports, active monitoring, diet and lifestyle protocols for healing, understanding your treatment options, and more.